Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies

Shuhan Liu,1– 3 Haisong Li,4 Shiwen Xi,1,2 Yuning Zhang,1,2,* Tianmeng Sun1,2,5,6,* 1Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 2Nation...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu S, Li H, Xi S, Zhang Y, Sun T
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/advancing-cns-therapeutics-enhancing-neurological-disorders-with-nanop-peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540629990637568
author Liu S
Li H
Xi S
Zhang Y
Sun T
author_facet Liu S
Li H
Xi S
Zhang Y
Sun T
author_sort Liu S
collection DOAJ
description Shuhan Liu,1– 3 Haisong Li,4 Shiwen Xi,1,2 Yuning Zhang,1,2,* Tianmeng Sun1,2,5,6,* 1Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 2National-Local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, People’s Republic of China; 3Cancer Center, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 4Department of Neurosurgery, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 5International Center of Future Science, Jilin University, Changchun, People’s Republic of China; 6State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, People’s Republic of China*These authors contributed equally to this workCorrespondence: Tianmeng Sun; Yuning Zhang, The First Hospital of Jilin University, 71 Xinmin St, Changchun, Jilin, People’s Republic of China, Email tsun41@jlu.edu.cn; zhangyuning@jlu.edu.cnAbstract: Given the complexity of the central nervous system (CNS) and the diversity of neurological conditions, the increasing prevalence of neurological disorders poses a significant challenge to modern medicine. These disorders, ranging from neurodegenerative diseases to psychiatric conditions, not only impact individuals but also place a substantial burden on healthcare systems and society. A major obstacle in treating these conditions is the blood-brain barrier (BBB), which restricts the passage of therapeutic agents to the brain. Nanotechnology, particularly the use of nanoparticles (NPs), offers a promising solution to this challenge. NPs possess unique properties such as small size, large surface area, and modifiable surface characteristics, enabling them to cross the BBB and deliver drugs directly to the affected brain regions. This review focuses on the application of NPs in gene therapy and enzyme replacement therapy (ERT) for neurological disorders. Gene therapy involves altering or manipulating gene expression and can be enhanced by NPs designed to carry various genetic materials. Similarly, NPs can improve the efficacy of ERT for lysosomal storage disorders (LSDs) by facilitating enzyme delivery to the brain, overcoming issues like immunogenicity and instability. Taken together, this review explores the potential of NPs in revolutionizing treatment options for neurological disorders, highlighting their advantages and the future directions in this rapidly evolving field.Keywords: central nervous system, nanoparticle, gene therapy, enzyme replacement therapy, lysosomal storage disorders, neurological disorders
format Article
id doaj-art-ce805eca786640728aea026ed3666c40
institution Kabale University
issn 1178-2013
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj-art-ce805eca786640728aea026ed3666c402025-02-04T17:15:41ZengDove Medical PressInternational Journal of Nanomedicine1178-20132025-02-01Volume 201443149099850Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement TherapiesLiu SLi HXi SZhang YSun TShuhan Liu,1– 3 Haisong Li,4 Shiwen Xi,1,2 Yuning Zhang,1,2,* Tianmeng Sun1,2,5,6,* 1Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 2National-Local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, People’s Republic of China; 3Cancer Center, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 4Department of Neurosurgery, The First Hospital, Jilin University, Changchun, Jilin, People’s Republic of China; 5International Center of Future Science, Jilin University, Changchun, People’s Republic of China; 6State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, People’s Republic of China*These authors contributed equally to this workCorrespondence: Tianmeng Sun; Yuning Zhang, The First Hospital of Jilin University, 71 Xinmin St, Changchun, Jilin, People’s Republic of China, Email tsun41@jlu.edu.cn; zhangyuning@jlu.edu.cnAbstract: Given the complexity of the central nervous system (CNS) and the diversity of neurological conditions, the increasing prevalence of neurological disorders poses a significant challenge to modern medicine. These disorders, ranging from neurodegenerative diseases to psychiatric conditions, not only impact individuals but also place a substantial burden on healthcare systems and society. A major obstacle in treating these conditions is the blood-brain barrier (BBB), which restricts the passage of therapeutic agents to the brain. Nanotechnology, particularly the use of nanoparticles (NPs), offers a promising solution to this challenge. NPs possess unique properties such as small size, large surface area, and modifiable surface characteristics, enabling them to cross the BBB and deliver drugs directly to the affected brain regions. This review focuses on the application of NPs in gene therapy and enzyme replacement therapy (ERT) for neurological disorders. Gene therapy involves altering or manipulating gene expression and can be enhanced by NPs designed to carry various genetic materials. Similarly, NPs can improve the efficacy of ERT for lysosomal storage disorders (LSDs) by facilitating enzyme delivery to the brain, overcoming issues like immunogenicity and instability. Taken together, this review explores the potential of NPs in revolutionizing treatment options for neurological disorders, highlighting their advantages and the future directions in this rapidly evolving field.Keywords: central nervous system, nanoparticle, gene therapy, enzyme replacement therapy, lysosomal storage disorders, neurological disordershttps://www.dovepress.com/advancing-cns-therapeutics-enhancing-neurological-disorders-with-nanop-peer-reviewed-fulltext-article-IJNcentral nervous systemnanoparticlegene therapyenzyme replacement therapylysosomal storage disordersneurological disorders
spellingShingle Liu S
Li H
Xi S
Zhang Y
Sun T
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
International Journal of Nanomedicine
central nervous system
nanoparticle
gene therapy
enzyme replacement therapy
lysosomal storage disorders
neurological disorders
title Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
title_full Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
title_fullStr Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
title_full_unstemmed Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
title_short Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
title_sort advancing cns therapeutics enhancing neurological disorders with nanoparticle based gene and enzyme replacement therapies
topic central nervous system
nanoparticle
gene therapy
enzyme replacement therapy
lysosomal storage disorders
neurological disorders
url https://www.dovepress.com/advancing-cns-therapeutics-enhancing-neurological-disorders-with-nanop-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT lius advancingcnstherapeuticsenhancingneurologicaldisorderswithnanoparticlebasedgeneandenzymereplacementtherapies
AT lih advancingcnstherapeuticsenhancingneurologicaldisorderswithnanoparticlebasedgeneandenzymereplacementtherapies
AT xis advancingcnstherapeuticsenhancingneurologicaldisorderswithnanoparticlebasedgeneandenzymereplacementtherapies
AT zhangy advancingcnstherapeuticsenhancingneurologicaldisorderswithnanoparticlebasedgeneandenzymereplacementtherapies
AT sunt advancingcnstherapeuticsenhancingneurologicaldisorderswithnanoparticlebasedgeneandenzymereplacementtherapies